GL1X · GenesisL1 explorer

Research workbench

Leukotriene A4 hydrolase complexed with inhibitor 4-[(2S)-2-{[4-(4- CHLOROPHENOXY)PHENOXY]METHYL}PYRROLIDIN-1-YL]BUTANOATE.

Analyse Leukotriene A4 hydrolase complexed with inhibitor 4-[(2S)-2-{[4-(4… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FH7
Type
protein
Length
607 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Leukotriene a-4 hydrolase
EC
3.3.2.6
UniProt
P09960
Ligands
25P, YB, ZN
Pockets
5 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALeukotriene a-4 hydrolase (EC 3.3.2.6)protein60743% helix, 23% strandP09960

Ligands and binding sites

  • 25P · 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}pyrrolidin-1-yl]butanoate · ligand · chains A
  • YB · Ytterbium (III) ion · metal · 3 copies · chains A
  • ZN · Zinc ion · metal · chains A
  • ACT · Acetate ion · additive · chains A
  • IMD · Imidazole · additive · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110520.850.868725P
21060.510.8220empty
31830.480.7626empty
41410.420.7530empty
5780.330.7514empty

Compared structures

  • 3FH7 · Leukotriene A4 Hydrolase complexed with inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • P09960 · AlphaFold monomer V2.0 prediction for leukotriene a-4 hydrolase (P09960) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.